NetraMark Holdings Inc. announced the appointment of Dr. Larry Alphs as its Chief Medical Officer (CMO). Dr. Alphs will play an important role in shaping the company's initiatives, further strengthening its commitment to providing cutting-edge generative AI solutions and improving clinical trial outcomes. Dr. Larry Alphs brings a wealth of experience to his role as CMO at NetraMark.

He is a distinguished physician with a track record of leadership in the pharmaceutical industry, having previously served in leadership roles that include Director at Novartis, Executive Director at Pfizer, Therapeutic Area Leader, Psychiatry at Johnson &Johnson, and President of The International Society for CNS Clinical Trials and Methodology (ISCTM). As CMO, Dr. Alphs will play a key role in the Company's strategic direction, spearhead introductions to key organizations and leverage his extensive industry network. His academic leadership will help shape the Company's publication strategy to demonstrate the effectiveness of the NetraMark technology through high impact publications.

The company also announced that Dr. DJ Cook, who has served as Netramark's CMO, will transition to join the NetraMark Advisory Board where he will continue to provide strategic guidance.